Eagle Ridge Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-12,059
| Closed | -$807K | – | 123 |
|
|
2015
Q3 | $807K | Sell |
12,059
-3,511
| -23% | -$235K | 0.21% | 80 |
|
|
2015
Q2 | $1.52M | Buy |
15,570
+636
| +4% | +$61.9K | 0.68% | 34 |
|
|
2015
Q1 | $1.4M | Buy |
14,934
+3,177
| +27% | +$297K | 0.63% | 35 |
|
|
2014
Q4 | $1.05M | Buy |
11,757
+1,271
| +12% | +$113K | 0.48% | 36 |
|
|
2014
Q3 | $724K | Hold |
10,486
| – | – | 0.35% | 39 |
|
|
2014
Q2 | $601K | Buy |
10,486
+7,944
| +313% | +$455K | 0.28% | 43 |
|
|
2014
Q1 | $101K | Buy |
+2,542
| New | +$101K | 0.05% | 57 |
|